Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are at higher-than-average risk of prostate cancer due to a strong family history of the disease and/or an inherited genetic mutation affecting DNA repair.
- People who have already been diagnosed with prostate cancer, or who have lesions (abnormal areas) that are considered suspicious for prostate cancer.
- People aged 18 years or older.
- People who are able to understand the study information and are willing to sign a written consent form agreeing to take part.
Who may not be able to join:
- No specific exclusion criteria have been listed for this trial (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ismail B Turkbey, M.D., National Cancer Institute (NCI)
Phone: (240) 760-6095
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Associations between imaging features and clinicopathological factors
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.